Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
源站原文 ↗Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
源站原文 ↗随着诺和诺德努力扭转局面，一些分析师表示，礼来拥有的优势可能有助于其保持在肥胖药物市场的领先地位。
摘要不可用(正文抓取失败或尚未完成);源提供文本与源站链接见左列。